Data / Form D filings / Repair Biotechnologies, Inc.
Repair Biotechnologies, Inc.: Form D filings
Repair Biotechnologies, Inc., a biotechnology company in Syracuse, NY, filed 10 Form D notices with the SEC between 2018 and 2025. The latest, on November 25, 2025, reports $5.3 million sold of a $11 million offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 841 E Fayette Street, Syracuse, NY, 13210
- Phone
- (315) 299-2407
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1750699
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | New notice | $11,000,000 | $5,258,906 | $5,741,094 | 16 | Nov 14, 2025 | sec.gov |
| Mar 26, 2024 | New notice | $50,000,000 | $6,166,000 | $43,834,000 | 7 | Mar 15, 2024 | sec.gov |
| Jun 16, 2023 | New notice | $8,625,520 | $8,389,479 | $236,041 | 38 | Jun 2, 2023 | sec.gov |
| Feb 23, 2021 | New notice | Indefinite | $200,000 | 2 | Feb 12, 2021 | sec.gov | |
| Sep 1, 2020 | New notice | $3,775,000 | $2,855,000 | $920,000 | 13 | Aug 25, 2020 | sec.gov |
| May 7, 2019 | Amendment | Indefinite | $2,150,000 | 15 | Mar 11, 2019 | sec.gov | |
| Mar 25, 2019 | New notice | Indefinite | $1,270,000 | 8 | Mar 11, 2019 | sec.gov | |
| Jan 23, 2019 | New notice | $75,000 | $75,000 | 1 | Jan 14, 2019 | sec.gov | |
| Aug 21, 2018 | Amendment | $550,000 | $450,000 | $100,000 | 6 | Jul 11, 2018 | sec.gov |
| Aug 21, 2018 | New notice | $550,000 | $450,000 | $100,000 | 6 | Jul 11, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Guilherme Cherman Perdigao de Oliveira | Executive Officer, Director | |
| Kelsey Moody | Director | |
| Reason N/A | Executive Officer, Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Nov 24, 2025 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Repair Biotechnologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.